Abion

Abion Current Ratio

The Current Ratio of Abion (203400.KQ) as of Oct 17, 2026 is -0.31. In the previous year, Current Ratio was 0.27 — a change of -213.42% (lower).

Current Ratio

-0.31

YoY

-213.42%

Last updated:

Current Ratio of Abion is 2025 -0.31 . Current Ratio of Abion was 2024 0.27 . It decreases by -213.42% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Abion Stock analysis

What does Abion do? Abion Inc, headquartered in Seoul, South Korea, operates in the Health Care sector, specifically within Biotechnology. The company develops biopharmaceuticals for treating incurable diseases and is listed on the stock market since July 21, 2014. Abion's business segments include product development and sales of diagnostic and research reagents, CRO services such as histopathology and molecular genetic analysis, and R&D for protein, nucleic acid, and antibody therapeutics. Abion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Abion stock

Current Ratio of Abion is -0.31 in 2025.

Current Ratio of Abion changed from 0.27 to -0.31, representing a -213.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Abion since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Abion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Abion

All Key Metrics — Abion